if you have overwhelming interest in the warrant offering then it would be oversubscribed and close quickly, instead, only $6.0 million of the $8.0 million has been subscribed for and it is being extended to Sept 15th
"KELOWNA, British Columbia, August 7, 2017 /PRNewswire/ --
Marapharm Ventures Inc. (MRPHF) (MDM.CN) (2M0.F) ("Marapharm" or the "Company") (www.marapharm.com/) announces that approximately $6 million of the common share warrants announced on July 5, 2017 have been reserved and/or paid for. Due to overwhelming interest, Marapharm decided that they will extend the warrant offering to September 15, 2017. Additionally, Marapharm will include new exemptions to make the offering more inclusive."
https://finance.yahoo.com/news/marapharm-ventures-inc-marapharm-clarifies-120000960.html?.tsrc=applewf
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM